Health Catalyst Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Health Catalyst Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
health catalyst公司股票: 對分析師觀點的深度剖析 (4個評級)
A clear picture of Health Catalyst's perception among...Throughout the last three months, 4 analysts have evaluated Health Catalyst (NASDAQ:HCAT), offering a diverse set of opinions from bullish to bearish.
在過去的三個月中，4位分析師對Health Catalyst（NASDAQ:HCAT）進行了評估，從看好到看淡提供了各種不同的觀點。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
In the assessment of 12-month price targets, analysts unveil insights for Health Catalyst, presenting an average target of $13.5, a high estimate of $16.00, and a low estimate of $11.00. Marking an increase of 1.28%, the current average surpasses the previous average price target of $13.33.
在12個月的目標價評估中，分析師揭示了Health Catalyst的見解，提供了平均目標價爲13.5美元，最高預估爲16.00美元，最低預估爲11.00美元的評估。目前的平均價格目標爲13.33美元，增長了1.28%。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析師評級：全面解析
A clear picture of Health Catalyst's perception among...
通過對近期分析師行...
登入免費觀看全文
登入/註冊